WhitleyRJSoongSJDolinRGalassoGJCh’ienLTAlfordCA. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis—National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977;297(6):289-294.
3.
TranTHStanescuDCaspers-VeluL, et al. Clinical characteristics of acute HSV-2 retinal necrosis. Am J Ophthalmol. 2004;137(5):872-879. doi:10.1016/j.ajo.2003.12.036.
4.
SchoenbergerSDKimSJThorneJE, et al. Diagnosis and treatment of acute retinal necrosis: a report by the American Academy of Ophthalmology. Ophthalmology. 2017;124(3):382-392. doi:10.1016/j.ophtha.2016.11.007.
5.
SköldenbergBForsgrenMAlestigK, et al. Acyclovir versus vidarabine in herpes simplex encephalitis: randomised multicentre study in consecutive Swedish patients. Lancet. 1984;2(8405):707-711.
6.
KimberlinDWLinCYJacobsRF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230-238.
7.
KinoshitaTHatanakaAMoriJAkaiwaKImaizumiH. Multimodal imaging of a severe case of neonatal acute retinal necrosis and lens vacuoles associated with herpes simplex virus infection [published online ahead of print February 4, 2021]. Ocul Immunol Inflamm. doi:10.1080/09273948.2020.1841803.
